Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Shandong Weigao Group Medical Polymer Co ( (HK:1066) ) has shared an update.
Shandong Weigao Group Medical Polymer Co., Ltd. has made an overseas regulatory announcement in compliance with the disclosure requirements of the Hong Kong Stock Exchange. The announcement, published on the Shanghai Stock Exchange’s website, reflects the company’s adherence to regulatory standards, potentially impacting its transparency and positioning in the market.
The most recent analyst rating on (HK:1066) stock is a Buy with a HK$7.50 price target. To see the full list of analyst forecasts on Shandong Weigao Group Medical Polymer Co stock, see the HK:1066 Stock Forecast page.
More about Shandong Weigao Group Medical Polymer Co
Shandong Weigao Group Medical Polymer Co., Ltd. is a company based in the People’s Republic of China, operating in the medical polymer industry. It specializes in the production of medical devices, with a focus on orthopaedic devices, and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 12,326,945
Technical Sentiment Signal: Hold
Current Market Cap: HK$30.89B
For detailed information about 1066 stock, go to TipRanks’ Stock Analysis page.